Non alcoholic Fatty Liver Disease Therapeutics Market

Non-alcoholic Fatty Liver Disease Therapeutics Market is projected to register a 13.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa非酒精性脂肪性肝病治疗药物市场预计将在2024年至2030年期间实现13.5%的复合年增长率。从地理角度来看，市场被划分为北美、欧洲、亚太地区、拉丁美洲、中东及非洲等主要区域。